Press Releases

Read Regulatory and non-regulatory press releases

  • All
  • Non-Regulatory
  • Regulatory
Non-Regulatory

OV – Oncology Venture to present at InvestorDagen in Copenhagen and invites Investors to join

Non-Regulatory

MPI – DRP predicts drug efficacy in breast cancer patients. New study on cornerstone drug epirubicin published in “Breast Cancer Research and Treatment”

Non-Regulatory

MPI: MPI has now executed transfer of the last tranche of the Oncology Venture shares sold during May

Non-Regulatory

MPI – Oncology Venture looks forward to publishing a clinical update on July 2

Non-Regulatory

MPI – MPI and Oncology Venture are merging – here are answers to When, How and What

Regulatory

MPI – Clinical data on PARP inhibitor 2X-121 and DRP response prediction validation to be presented on the world’s largest cancer congress ASCO 2018

Regulatory

MPI has sold its holdings in Oncology Venture

Regulatory

MPI – Change in Board of directors

Regulatory

MPI – Resolution to implement merger

Non-Regulatory

MPI: Medical Prognosis Institute and Oncology Venture Announces Abstracts on Three Pipeline Products Selected for 2018 ASCO Clinical Meeting

Regulatory

MPI – Publication of Merger Prospectus

Regulatory

MPI – NOTICE TO CONVENE EXTRAORDINARY GENERAL MEETING

Regulatory

MPI – Publication of merger plan related to the merger between MPI and Oncology Venture

Regulatory

MPI – Today, April 24, 2018, the annual general meeting 2018 in Medical Prognosis Institute A/S was held

Regulatory

MPI’s CEO exercises warrants – increase of share capital in the company

Regulatory

MPI – Oncology Venture exercises option to inlicense Dovitinib a Phase 3 Multi Tyrosine Kinase Inhibitor

Regulatory

MPI – Notice to convene ordinary annual general meeting

Regulatory

Claus Frisenberg Pedersen, CFO in Oncology Venture buys shares in Oncology Venture and MPI

Regulatory

MPI publishes Annual report for 2017

Non-Regulatory

MPI – New earlier date for publication of the annual report